Literature DB >> 72406

Quantitative and qualitative estimations of IgE bound to basophil leukocytes from hay fever patients.

P S Skov, H Permin, H J Malling.   

Abstract

IgE was removed from human basophils of 4 nonatopic persons and 10 hay fever patients allergic to timothy grass pollen by treating the cells with buffer adjusted to pH 4. IgE could be removed and refixed to the same cells. Refixation was demonstrated by immunofluorescence and by the ability of basophils to release histamine on exposure to timothy pollen. Removed total IgE and specific IgE directed against timothy pollen were estimated, and a linear correlation to the level of total IgE and specific IgE in serum was found. The total number of IgE molecules per basophil was calculated to be in the range of 30,000 to 300,000, and timothy-specific IgE constituted 4%-15% of the total IgE molecules on the cells. It was furthermore established that specific cell-bound IgE was linearly correlated to the pollen concentration releasing 20% of the histamine contents of the basophils. Separated 2gE from sensitized and nonsensitized basophils could be bound to basophils from other patients, resulting in a change in cell sensitivity. This could be ascribed to additional binding to free cell receptors as well as to a partial replacement of bound IgE. Basophils from non-atopic persons could not be sensitized by incubation with surface IgE from atopic persons. The results indicate that acid treatment is a simple method suitable for removing IgE from basophils. This IgE is intact and can be quantitated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72406     DOI: 10.1111/j.1365-3083.1977.tb00338.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  15 in total

1.  Bacteria-induced histamine release. Examination of the bacterial cell wall components peptidoglycan, teichoic acid and protein A.

Authors:  S Norn; P Stahl Skov; C Jensen; F Espersen; J O Jarløv
Journal:  Agents Actions       Date:  1985-04

2.  Microfungi in indoor air are able to trigger histamine release by non-IgE-mediated mechanisms.

Authors:  F O Larsen; L H Christensen; P Clementsen; S Gravesen; P Stahl Skov; S Norn
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

3.  Passive in vitro sensitization of human basophils with Dermatophagoides farinae specific IgE.

Authors:  A Weyer; P Ougen; J P Dandeu; F Marchand; B David
Journal:  Agents Actions       Date:  1986-04

4.  Endotoxins release histamine by complement activation and potentiate bacteria-induced histamine release.

Authors:  S Norn; C Jensen; B T Dahl; P Stahl Skov; L Baek; H Permin; J O Jarløv; H Sørensen
Journal:  Agents Actions       Date:  1986-04

5.  Bacteria and their products peptidoglycan and teichoic acid potentiate antigen-induced histamine release in allergic patients.

Authors:  S Norn; J O Jarløv; C B Jensen; P Clementsen; B T Dahl; F Espersen; P Stahl Skov
Journal:  Agents Actions       Date:  1987-04

6.  Basophil sensitivity and reactivity to monoclonal anti-human IgE after in vitro sensitization with human myeloma IgE.

Authors:  A Weyer; J L Guesdon; P Ougen; F Marchand; B David
Journal:  Agents Actions       Date:  1987-04

7.  Passive sensitization of human intestinal mast cells.

Authors:  H Nolte; A Kruse; P Stahl Skov; P O Schiøtz
Journal:  Agents Actions       Date:  1989-04

8.  Hyperosmolarity selectively enhances IgE-receptor-mediated histamine release from human basophils.

Authors:  B W Nielsen; T Bjerke; T M Damsgaard; T Herlin; K Thestrup-Pedersen; P O Schiøtz
Journal:  Agents Actions       Date:  1992-03

9.  A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function.

Authors:  C S Ulrik; V Backer; A Dirksen
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

10.  Intrinsic asthma and bacterial histamine release.

Authors:  S Norn; P Stahl Skov; C Kock; P Andersen; M Pedersen; P Tønnesen; P S Pedersen; N E Møller; J Hertz; N Høiby
Journal:  Agents Actions       Date:  1982-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.